<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain><z:chebi fb="0" ids="35218,38697">Anthocyanins</z:chebi> are a class of <z:chebi fb="0" ids="26195">polyphenols</z:chebi> abundant in the skins of red grapes, and have been shown to have anti-<z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e> effects in models of <z:hpo ids='HP_0003003'>colon cancer</z:hpo> [Cooke et al </plain></SENT>
<SENT sid="1" pm="."><plain>Int J <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">Cancer</z:e> 2006;119:2213-2220; Jing et al </plain></SENT>
<SENT sid="2" pm="."><plain>J Agric Food Chem 2008;56:9391-9398] </plain></SENT>
<SENT sid="3" pm="."><plain>Gut microflora metabolize <z:chebi fb="0" ids="35218,38697">anthocyanins</z:chebi> to phenolic acids and <z:chebi fb="5" ids="17478">aldehydes</z:chebi> </plain></SENT>
<SENT sid="4" pm="."><plain>These metabolites may explain the relationship between anthocyanin consumption and reduced incidence of <z:e sem="disease" ids="C1527249,C0009402" disease_type="Neoplastic Process" abbrv="">colorectal cancer</z:e> (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CRC</z:e>) </plain></SENT>
<SENT sid="5" pm="."><plain>Previously, <z:chebi fb="0" ids="30778">gallic acid</z:chebi> (<z:chebi fb="125" ids="28260">Gal</z:chebi>), <z:chebi fb="0" ids="28647">3-O-methylgallic acid</z:chebi> (Megal), and 2,4,6-trihydroxybenzaldehyde (THBA) were found to decrease Caco-2 cell viability to a larger extent than other anthocyanin metabolites </plain></SENT>
<SENT sid="6" pm="."><plain>To better understand the potential anti-<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CRC</z:e> action of these compounds, this paper investigated their capacity to modulate the cell cycle, and induce apoptotic cell <z:hpo ids='HP_0011420'>death</z:hpo> </plain></SENT>
<SENT sid="7" pm="."><plain>Dividing Caco-2 cells were incubated for 24-72 h in the presence of 10-100 µM <z:chebi fb="125" ids="28260">Gal</z:chebi>, Megal, THBA, and malvidin-3-<z:chebi fb="3" ids="15903">glucoside</z:chebi> (M3g) </plain></SENT>
<SENT sid="8" pm="."><plain>THBA reduced cell viability only at 100 µM, while <z:chebi fb="125" ids="28260">Gal</z:chebi> and Megal (10-100 µM) caused a time- and dose-dependent decrease in cell viability </plain></SENT>
<SENT sid="9" pm="."><plain>After 72��h incubation, the metabolites caused cell cycle arrest at G(0) /G(1)  </plain></SENT>
<SENT sid="10" pm="."><plain>The activation of the apoptotic pathway by Megal, <z:chebi fb="125" ids="28260">Gal</z:chebi>, and THBA was evidenced by the activation of caspase-3 </plain></SENT>
<SENT sid="11" pm="."><plain>However, only Megal and <z:chebi fb="125" ids="28260">Gal</z:chebi> caused DNA fragmentation and nuclear condensation </plain></SENT>
<SENT sid="12" pm="."><plain>Megal, <z:chebi fb="125" ids="28260">Gal</z:chebi>, and THBA inhibited transcription factors NF-κB, AP-1, STAT-1, and OCT-1 which are known to be activated in <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CRC</z:e> </plain></SENT>
<SENT sid="13" pm="."><plain>In conclusion, the anti-<z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e> effects of Megal and <z:chebi fb="125" ids="28260">Gal</z:chebi> occurs as a consequence of both the inhibition of cell proliferation and induction of <z:mpath ids='MPATH_3'>apoptosis</z:mpath> </plain></SENT>
<SENT sid="14" pm="."><plain>The inhibition of transcription factors that promote cell proliferation and survival can in part underlie the observed effects. © 2012 Wiley Periodicals, Inc </plain></SENT>
</text></document>